Literature DB >> 3175452

AA amyloidosis associated with systemic lupus erythematosus.

E J ter Borg1, S Janssen, M H van Rijswijk, J Bijzet, P E de Jong, J D Elema, C G Kallenberg.   

Abstract

A 54-year-old female with a 23-year history of systemic lupus erythematosus was admitted because of loss of renal function and nephrotic syndrome. Renal biopsy showed deposition of AA amyloid as demonstrated by Congo red staining and reactivity with protein AA-specific antibodies. Immune deposits were present in the mesangium and the glomerular basement membrane, but histopathological changes consistent with lupus nephritis were not detected. The rare association of systemic lupus erythematosus and amyloidosis is discussed in view of the characteristics of the acute phase reaction in systemic lupus erythematosus.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3175452     DOI： 10.1007/bf00272437

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  15 in total

1.  Amyloidosis of the kidneys, adrenals and spleen as a complication of acute disseminated lupus erythematosus treated with ACTH and cortisone.

Authors:  O WEGELIUS
Journal:  Acta Med Scand       Date:  1956-12-08

2.  Renal amyloidosis: development in a case of systemic lupus erythematosus.

Authors:  R W King; W F Falls
Journal:  Clin Nephrol       Date:  1976-11       Impact factor: 0.975

3.  Systemic lupus erythematosus and amyloidosis.

Authors:  S Webb; F Segura; F Cervantes; A Darnell; E Soriano; M Ribas-Mundo; J García-San Miguel
Journal:  Arthritis Rheum       Date:  1979-05

Review 4.  C-reactive protein in SLE.

Authors:  M B Pepys; J G Lanham; F C De Beer
Journal:  Clin Rheum Dis       Date:  1982-04

5.  Lupus erythematosus in a patient with amyloidosis, adrenal insufficiency, and subsequent immunoblastic sarcoma: demonstration of the LE phenomenon in the lung.

Authors:  L A Schleissner; W W Sheehan; R C Orselli
Journal:  Arthritis Rheum       Date:  1976 Mar-Apr

6.  Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus.

Authors:  G J Becker; M Waldburger; G R Hughes; M B Pepys
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

7.  Ten years' experience of an amyloid clinic--a clinicopathological survey.

Authors:  M J Browning; R A Banks; C R Tribe; P Hollingworth; C Kingswood; J C Mackenzie; P A Bacon
Journal:  Q J Med       Date:  1985-03

8.  Amyloidosis in systemic lupus erythematosus.

Authors:  D P Huston; K P McAdam; J E Balow; R Bass; R A DeLellis
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

9.  Pulmonary amyloidosis associated with systemic lupus erythematosus.

Authors:  S Nomura; N Kumagai; T Kanoh; H Uchino; J Kurihara
Journal:  Arthritis Rheum       Date:  1986-05

10.  Classification of amyloidosis: immunohistochemistry versus the potassium permanganate method in differentiating AA from AL amyloidosis.

Authors:  S Janssen; J D Elema; M H van Rijswijk; P C Limburg; S Meijer; E Mandema
Journal:  Appl Pathol       Date:  1985
View more
  2 in total

1.  Tocilizumab-induced remission of nephrotic syndrome accompanied by secondary amyloidosis and glomerulonephritis in a patient with rheumatoid arthritis.

Authors:  Shunsuke Yamada; Akihiro Tsuchimoto; Yoshiki Kaizu; Masatomo Taniguchi; Kosuke Masutani; Hiroshi Tsukamoto; Hiroaki Ooboshi; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  CEN Case Rep       Date:  2014-07-29

2.  AA amyloidosis associated with systemic lupus erythematosus: impact on clinical course and outcome.

Authors:  Banu Aktas Yilmaz; Nursen Düzgün; Türkan Mete; Levent Yazicioglu; Müyesser Sayki; Arzu Ensari; Sehsuvar Ertürk
Journal:  Rheumatol Int       Date:  2007-08-09       Impact factor: 2.631
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.